I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Effectiveness and safety of edoxaban versus warfarin in pat..:
Mohammed M. Alsultan
;
Abdullah K. Alahmari
;
Mansour A. Mahmoud
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1276491/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1276491
RT Journal T1
Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7538e14af63e4347959d9490c269a33b&Exemplar=1&LAN=DE A1 Mohammed M. Alsultan A1 Abdullah K. Alahmari A1 Mansour A. Mahmoud A1 Ziyad S. Almalki A1 Wafa Alzlaiq A1 Faisal Alqarni A1 Fahad Alsultan A1 Nehad Jaser Ahmed A1 Ahmed O. Alenazi A1 Lucas Scharf A1 Jeff Jianfei Guo PB Frontiers Media S.A. YR 2023 K1 atrial fibrillation K1 warfarin K1 DOACs K1 edoxaban K1 safety and effectiveness K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1276491/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1276491 DO https://doi.org/10.3389/fphar.2023.1276491 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)